Published in Psychoneuroendocrinology on April 01, 1997
Acute glucocorticoid administration rapidly suppresses basal and stress-induced hypothalamo-pituitary-adrenal axis activity. Endocrinology (2011) 0.85
Adrenocortical responsiveness to infusions of physiological doses of ACTH is not altered in posttraumatic stress disorder. Front Behav Neurosci (2009) 0.76
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry (1965) 5.09
Biogenic amines and emotion. Science (1967) 3.49
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med (1987) 2.83
A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA (1997) 2.80
Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry (2000) 2.70
Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res (1999) 2.49
DNA replication licensing and human cell proliferation. J Cell Sci (2001) 2.30
Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med (1980) 2.15
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry (1998) 2.13
Spontaneous recurrent hypothermia accompanying agenesis of the corpus callosum. Brain (1969) 2.10
Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med (1981) 1.97
Cdc6 protein causes premature entry into S phase in a mammalian cell-free system. EMBO J (1998) 1.95
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol (1968) 1.86
Accentuated vascular and endocrine response to SQ 20881 in hypertension. N Engl J Med (1977) 1.83
Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest (1980) 1.76
Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry Suppl (1998) 1.73
Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med (1973) 1.65
Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension (1999) 1.64
The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis. J Lab Clin Med (1972) 1.62
Social functioning in depression: a review. J Clin Psychiatry (2000) 1.62
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study. Am J Psychiatry (2000) 1.61
Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest (1974) 1.59
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochem Pharmacol (1967) 1.54
Gender differences in chronic major and double depression. J Affect Disord (2000) 1.53
Familial hypo-beta-lipoproteinemia: a genetic disorder of lipid metabolism with nervous system involvement. Am J Med (1969) 1.51
Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology (2000) 1.50
Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. N Engl J Med (1984) 1.49
Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1997) 1.46
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord (1999) 1.45
Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med (Berl) (2001) 1.43
Dilative cardiomyopathy leading to congestive heart failure in a male squirrel monkey (Saimiri sciureus). J Med Primatol (2000) 1.42
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42
Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol Psychiatry (2007) 1.40
Psychopharmacological screening criteria. APA Committee on Research on Psychiatric Treatments. J Clin Psychiatry (1992) 1.39
Glucocorticoid-remediable aldosteronism. Cardiovasc Res (1996) 1.38
The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol (1999) 1.38
Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res (2001) 1.34
A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res (1985) 1.33
Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med (1977) 1.31
Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension (1981) 1.31
Early life stress and inherited variation in monkey hippocampal volumes. Arch Gen Psychiatry (2001) 1.29
Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol Appl Neurobiol (2001) 1.28
Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension. N Engl J Med (1979) 1.27
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res (2001) 1.26
Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation (1993) 1.26
Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet (1999) 1.24
Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension (1981) 1.23
Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry (1999) 1.21
Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol (2001) 1.21
Regulation of aldosterone secretion. Annu Rev Physiol (1988) 1.20
Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading. J Clin Invest (1972) 1.20
Potassim-aldosterone-renin interrelationships. J Clin Endocrinol Metab (1975) 1.20
Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int (1981) 1.20
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Corticosteroids and cognition. J Psychiatr Res (2001) 1.18
Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest (1983) 1.16
Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. J Clin Invest (1976) 1.16
Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. J Clin Invest (1975) 1.16
Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens (1996) 1.16
Heterogenous inositol tetrakisphosphate binding sites in the adrenal cortex. J Biol Chem (1988) 1.15
Benzodiazepines in depressive disorders. Arch Gen Psychiatry (1978) 1.15
24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry (2000) 1.15
Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry (2000) 1.15
Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. Arch Intern Med (1999) 1.15
The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. J Neuropsychiatry Clin Neurosci (1995) 1.14
Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens (2001) 1.12
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension (1998) 1.12
DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Br J Cancer (2005) 1.12
Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens (2006) 1.12
Melatonin rhythm observed throughout a three-cycle bright-light stimulus designed to reset the human circadian pacemaker. J Biol Rhythms (1999) 1.09
Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension (1999) 1.09
Studies of the control of plasma aldosterone concentration in normal man. II. Effect of dietary potassium and acute potassium infusion. J Clin Invest (1972) 1.09
Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers. Neurology (2005) 1.07
The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment. Psychopharmacol Bull (1974) 1.06
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry (1998) 1.05
Calcium oscillations in single adrenal glomerulosa cells stimulated by angiotensin II. Proc Natl Acad Sci U S A (1988) 1.04
Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. Br J Cancer (2009) 1.04
Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys. J Neurosci (2000) 1.03
Abnormal responsiveness of the renin aldosterone system to acute stimulation in patients with essential hypertension. Ann Intern Med (1970) 1.03
Screening for postpartum depression. An antepartum questionnaire. J Reprod Med (1997) 1.02
Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. Am J Med (1981) 1.02
Quality of life and its impact on hypertensive patients. Am J Med (1987) 1.02
Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Biol Psychiatry (1989) 1.01
Nicotine patch and paroxetine for smoking cessation. J Consult Clin Psychol (2000) 1.01
Electrical properties of isolated rat adrenal glomerulosa and fasciculata cells. Endocrinology (1987) 1.01
Effect of sodium intake on insulin sensitivity. Am J Physiol (1993) 1.01
Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men. Am J Cardiol (1992) 1.01
Angiotensin-converting enzyme inhibition and prostaglandins. Am J Cardiol (1982) 1.00
Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol (2007) 1.00
Heroin use as an attempt to cope: clinical observations. Am J Psychiatry (1974) 1.00
beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation. Br J Clin Pharmacol (1979) 0.99
Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. Am J Psychiatry (1973) 0.99
Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am J Hypertens (2001) 0.99
Gender differences in presentation of chronic major depression. Psychopharmacol Bull (1995) 0.98
Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry (2001) 0.97
Electrophysiological responses to angiotensin II of isolated rat adrenal glomerulosa cells. Endocrinology (1987) 0.97